Unlocking the power of computational modelling and simulation across the product lifecycle in life sciences: A UK Landscape Report
Year: 2023
Type: book
Abstract: This report Outlines the public health and economic benefits of using in silico technologies (ISTs) to refine, reduce, and even replace the need for conventional human clinical trials and animal and physical testing in the development of new medical products, Describes current barriers to the expanded use of ISTs, Identifies opportunities for the UK to spearhead the global effort to develop ISTs, making the UK a leader in the field and, therefore, friendly to inward investors, Details the significant commercial and economic benefits in the development of the UK life sciences sector and broader societal benefits to the NHS, UK, and the world in general, Makes recommendations on how the UK government can support this industrial and regulatory transition.
Authors: Frangi, AF, Denison, T, Myles, P, Ordish, J, Brown, P, Turpin, R, Kipping, M, Palmer, M, Flynn, D, Afshari, P, Lane, C, de Cunha, M, Horner, M, Levine, S, Marchal, T, Bryan, R, Tunbridge, G, Pink, J, Macpherson, S, Niederer, S, Shipley, R, Dall'Ara, E, Maeder, T, Thompson, M
Institutions: University of Leeds, University of Oxford, Medicines and Healthcare products Regulatory Agency, Association of British HealthTech Industries, British Standards Institution, Medtronic (United States), Boston Scientific (United States), Johnson & Johnson (United States), Philips (Netherlands), Edwards Lifesciences (United States), Edwards Lifesciences (Switzerland), Dassault Systèmes (France), Synopsys (United States), Imperial College London, University College London, University of Sheffield
Language: English
Subfield: Small Animals
Field: Veterinary
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6912852462